Fibrinogen‐ and Fibrin‐Degradation Products during Fibrinolytic Therapya

This publication has 47 references indexed in Scilit:

• Fibrinogen in Arterial and Inflammatory Diseases Fibrinogen A?? and ??-chain dimers as potential differential indicators of atherosclerotic and thrombotic vascular disease
  Blood Coagulation & Fibrinolysis, 1990
• Specific identification of fibrin(ogen) degradation products in plasma and serum using blotting and peroxidase labeled antiserum
  American Journal of Hematology, 1990
• Relation of plasma D-dimer concentrations to coronary artery reperfusion before and after thrombolytic treatment in patients with acute myocardial infarction
  The American Journal of Cardiology, 1989
• Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism
  American Heart Journal, 1988
• Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator.
  Journal of Clinical Investigation, 1987
• Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems
  British Journal of Haematology, 1985
• Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
  Journal of Clinical Investigation, 1985
• Characterization of Serum Fibrinogen and Fibrin Fragments Produced during Disseminated Intravascular Coagulation
  British Journal of Haematology, 1978
• Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke.
  Stroke, 1976
• γ-γ Cross-linking sites in human and bovine fibrin
  Biochemistry, 1971